These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 8655375

  • 1. Concurrent cisplatin-vindesine and hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer.
    Le Péchoux C, Arriagada R, Le Chevalier T, Bretel JJ, Cosset BP, Ruffié P, Baldeyrou P, Grunenwald D.
    Int J Radiat Oncol Biol Phys; 1996 Jun 01; 35(3):519-25. PubMed ID: 8655375
    [Abstract] [Full Text] [Related]

  • 2. [Optimization of combined radiotherapy and chemotherapy in treatment of non-small cell lung carcinoma].
    Bretel JJ, Arriagada R, Le Chevalier T, Baldeyrou P, Grunenwald D, Le Péchoux C, Pellae-Cosset B, Ruffié P.
    Cancer Radiother; 1997 Jun 01; 1(2):148-53. PubMed ID: 9273186
    [Abstract] [Full Text] [Related]

  • 3. Alternating radiotherapy and chemotherapy for inoperable Stage III non-small-cell lung cancer: long-term results of two Phase II GOTHA trials. Groupe d'Oncologie Thoracique Alpine.
    Mirimanoff RO, Moro D, Bolla M, Michel G, Brambilla C, Mermillod B, Miralbell R, Alberto P.
    Int J Radiat Oncol Biol Phys; 1998 Oct 01; 42(3):487-94. PubMed ID: 9806505
    [Abstract] [Full Text] [Related]

  • 4. Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601).
    Tsuchiya S, Ohe Y, Sugiura T, Fuwa N, Kitamoto Y, Mori K, Kobayashi H, Nakata K, Sawa T, Hirai K, Etoh T, Saka H, Saito A, Fukuda H, Ishizuka N, Saijo N, Japan Clinical Oncology Group Study.
    Jpn J Clin Oncol; 2001 Oct 01; 31(10):488-94. PubMed ID: 11696618
    [Abstract] [Full Text] [Related]

  • 5. Mitomycin, cisplatin, and vindesine followed by radiotherapy combined with cisplatin in stage III nonsmall cell lung cancer: long-term results.
    Tejedor M, Valerdi JJ, López R, Domínguez MA, Arias F, Illarramendi JJ, Martínez E.
    Int J Radiat Oncol Biol Phys; 1995 Feb 15; 31(4):813-8. PubMed ID: 7860393
    [Abstract] [Full Text] [Related]

  • 6. A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer.
    Atagi S, Kawahara M, Hosoe S, Ogawara M, Kawaguchi T, Okishio K, Naka N, Sunami T, Mitsuoka S, Akira M.
    Lung Cancer; 2002 Apr 15; 36(1):105-11. PubMed ID: 11891041
    [Abstract] [Full Text] [Related]

  • 7. Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.
    Reboul F, Brewer Y, Vincent P, Chauvet B, Faure CF, Taulelle M.
    Int J Radiat Oncol Biol Phys; 1996 May 01; 35(2):343-50. PubMed ID: 8635942
    [Abstract] [Full Text] [Related]

  • 8. [Concurrent high-dose thoracic irradiation plus daily low-dose cisplatin and vindesine in locally advanced unresectable stage III non-small cell lung cancer].
    Nakano K, Kumagai K, Ishida H, Kohjima N, Hiramoto T, Hada Y.
    Gan To Kagaku Ryoho; 1996 Jan 01; 23(1):57-61. PubMed ID: 8546470
    [Abstract] [Full Text] [Related]

  • 9. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y, Ueoka H, Kiura K, Kamei H, Tabata M, Sakae K, Hiraki Y, Kawahara S, Eguchi K, Hiraki S, Harada M.
    Br J Cancer; 2000 Jan 01; 82(1):104-11. PubMed ID: 10638975
    [Abstract] [Full Text] [Related]

  • 10. Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer. Southern Osaka Lung Cancer Study Group.
    Furuse K, Kubota K, Kawahara M, Kodama N, Ogawara M, Akira M, Nakajima S, Takada M, Kusunoki Y, Negoro S.
    J Clin Oncol; 1995 Apr 01; 13(4):869-75. PubMed ID: 7707113
    [Abstract] [Full Text] [Related]

  • 11. A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high-dose radiotherapy only in locally advanced non-small-cell lung cancer. An EORTC Lung Cancer Cooperative Group trial.
    Planting A, Helle P, Drings P, Dalesio O, Kirkpatrick A, McVie G, Giaccone G.
    Ann Oncol; 1996 Feb 01; 7(2):139-44. PubMed ID: 8777169
    [Abstract] [Full Text] [Related]

  • 12. Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.
    Pujol JL, Lafontaine T, Quantin X, Reme-Saumon M, Cupissol D, Khial F, Michel FB.
    Chest; 1999 Jan 01; 115(1):144-50. PubMed ID: 9925076
    [Abstract] [Full Text] [Related]

  • 13. Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study.
    Frasci G, Comella P, Scoppa G, Guida C, Gravina A, Fiore F, Casaretti R, Daponte A, Parziale A, Comella G.
    J Clin Oncol; 1997 Apr 01; 15(4):1409-17. PubMed ID: 9193333
    [Abstract] [Full Text] [Related]

  • 14. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
    Vokes EE, Haraf DJ, Drinkard LC, Hoffman PC, Ferguson MK, Vogelzang NJ, Watson S, Lane NJ, Golomb HM.
    Cancer Chemother Pharmacol; 1995 Apr 01; 35(4):304-12. PubMed ID: 7530173
    [Abstract] [Full Text] [Related]

  • 15. Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancer.
    Lee SW, Choi EK, Lee JS, Lee SD, Suh C, Kim SW, Kim WS, Ahn SD, Yi BY, Kim JH, Noh YJ, Kim SS, Koh Y, Kim DS, Kim WD.
    Int J Radiat Oncol Biol Phys; 2003 Jul 15; 56(4):996-1004. PubMed ID: 12829135
    [Abstract] [Full Text] [Related]

  • 16. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
    Bonner JA, McGinnis WL, Stella PJ, Marschke RF, Sloan JA, Shaw EG, Mailliard JA, Creagan ET, Ahuja RK, Johnson PA.
    Cancer; 1998 Mar 15; 82(6):1037-48. PubMed ID: 9506347
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04.
    Komaki R, Scott C, Ettinger D, Lee JS, Fossella FV, Curran W, Evans RF, Rubin P, Byhardt RW.
    Int J Radiat Oncol Biol Phys; 1997 Apr 01; 38(1):149-55. PubMed ID: 9212017
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
    Leyvraz S, Pasche P, Bauer J, Bernasconi S, Monnier P.
    J Clin Oncol; 1994 Sep 01; 12(9):1876-85. PubMed ID: 8083711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.